Whether so-called micro-hospitals can succeed financially might depend on whether they can meet Medicare’s definition of a hospital: a medical facility that dedicates the bulk of its services to inpatient care.
U.S. Health and Human Services Secretary Alex Azar told lawmakers that it may be time to eliminate the complex system of rebates that drug companies and pharmacy-benefit managers use to negotiate and set prices.
The Indianapolis-based pharmaceutical giant said it plans to acquire ARMO BioSciences Inc., which is working on treatments that activate the immune system of cancer patients to recognize and eradicate tumors.
The work-play-live district for innovation and entrepreneurship being developed on the near-northwest side will include research labs, apartments and bicycle trails—which could help to attract young workers.
DowDuPont Inc. is working on a series of deals to tighten the focus at two of the three spinoffs it plans for next year, including the Corteva Agriscience spinoff, which includes the Indianapolis operations of the former Dow AgroSciences unit.
The 30-acre first phase of the 16 Tech innovation district, long touted as an up-and-coming hub for entrepreneurship and innovation, will be spurred by a $120 million investment from Browning and a $38 million grant from Lilly Endowment.
Its $1.5 million investment is expected to help B2S Life Sciences more than double its staff and grow its client base, which includes contract research groups, pharmaceutical firms and biotech startups.
The funds includes $7.6 million to study early-onset Alzheimer’s disease, $5.2 million to fund a clinical and translational sciences institute, and $4.8 million to fund epidemiologic databases to evaluate AIDS care in Africa.